The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.
Study with transgender women suggests taking on-demand PrEP with hormone therapy may result in drug levels too low for HIV prevention.
Harm reduction for the 15.6 million people who inject drugs remains a critical cornerstone to respond to the global epidemics of HIV and hepatitis C – but progress has stagnated.
On International Youth Day (12 August), we look at the importance of youth involvement and safe spaces to respond to the HIV challenge related to the youth bulge.
Long-term survivors – those diagnosed before effective treatment for HIV was around – face unique challenges relating to their mental and physical health.
Juno Roche – writer, campaigner and woman living with HIV – shares her experiences on risk, HIV and being trans for International Transgender Day of Visibility (31 March).
Language matters. Changing how people who use drugs are treated requires changing how we speak about them.
A ground-breaking review provides stark evidence of the damage criminalisation has on preventing and treating HIV among people who inject drugs.
The UNODC highlights disease burden, increased opioid abuse and a lack of treatment access in their global state of drug use report.
According to a recent report, 12 million people inject drugs globally, but they are often simply judged, looked down on, condemned or ignored. This has serious health and social consequences for them, their families and their communities – not least in terms of their risk of acquiring or passing on HIV and hepatitis C.
People who inject drugs are increasingly left behind in the HIV response, with limited access to harm reduction services that secure their rights and their health.
